Colonic Cl channel blockade by three classes of compounds.
We compared the potency and inhibitory actions of three different classes of organic acids on a Cl channel derived from colonic enterocyte plasma membrane vesicles. Chloride channels were incorporated into planar lipid bilayer membranes to examine the effects of the anthranilic acids, diphenylamine 2-carboxylic acid (DPC) and 5-nitro-2-(3-phenylpropylamino)benzoic acid (NPPB), the indanyl alkanoic acids, 2-[(2-cyclopentyl-6,7-dichloro-2,3-dihydro-2-methyl-1-oxo-1H-inden -5-yl)oxy] acetic acid (IAA-94) and its stereoenantiomer IAA-95, and the disulfonic stilbene, 4,4'-dinitro-stilbene-2,2'-disulfonic acid (DNDS). Except for DNDS, each of the blockers was equipotent from both the outer membrane and the cytoplasmic side of the channel protein. The potency order from the outmembrane side was DNDS greater than IAA-94 = IAA-95 greater than NPPB much greater than DPC. In contrast, the potency order from the cytoplasmic side was IAA-94 = IAA-95 greater than NPPB greater than DNDS much greater than DPC. DPC and NPPB caused a concentration-dependent decrease in the single-channel conductance (fast block). DNDS, IAA-94, and IAA-95 caused a flickery-type block and a concentration-dependent decrease in open-channel probability. Kinetic analysis revealed that blockade could be explained by a linear closed-opened-blocked kinetic scheme. Similarities in the electrostatic potential maps of these open-channel blockers suggest they may bind to a single shared binding site within the channel protein.
Singh
A K
AK
Department of Physiology and Biophysics, University of Alabama, Birmingham 35294.
Afink
G B
GB
Venglarik
C J
CJ
Wang
R P
RP
Bridges
R J
RJ
D000818:Animals; D018118:Chloride Channels; D002712:Chlorides / Q000378:metabolism*; D003106:Colon / Q000187:drug effects / Q000378:metabolism*; D004232:Diuretics / Q000494:pharmacology; D004594:Electrophysiology; D005260:Female; D006016:Glycolates / Q000494:pharmacology*; D007473:Ion Channels / Q000187:drug effects* / Q000378:metabolism; D007700:Kinetics; D008051:Lipid Bilayers; D008565:Membrane Proteins / Q000187:drug effects / Q000378:metabolism; D008958:Models, Molecular; D009579:Nitrobenzoates / Q000494:pharmacology*; D051381:Rats; D011919:Rats, Inbred Strains; D013237:Stereoisomerism; D013267:Stilbenes / Q000494:pharmacology; D062367:ortho-Aminobenzoates / Q000494:pharmacology*
D018118:Chloride Channels; D002712:Chlorides; D004232:Diuretics; D006016:Glycolates; D007473:Ion Channels; D008051:Lipid Bilayers; D008565:Membrane Proteins; D009579:Nitrobenzoates; D013267:Stilbenes; D062367:ortho-Aminobenzoates; C058176:5-nitro-2-(3-phenylpropylamino)benzoic acid; C015765:MK 473; C022306:4,4'-dinitro-2,2'-stilbenedisulfonic acid; C001209:fenamic acid